[1]
2015. Dose-dense weekly paclitaxel and carboplatin compared with conventional paclitaxel and carboplatin treatment for stage II-IV ovarian cancer patients. Bangladesh Journal of Pharmacology. 10, 3 (Jul. 2015), 489–493. DOI:https://doi.org/10.3329/bjp.v10i3.23079.